Significance We report that suppression of the serine protease elastase reshapes innate responses induced by injected vaccines containing alum adjuvant. This reprogramming improves the induction of protective antibodies in the bloodstream and stimulates innate signals, which support the development of antibody responses in mucosal tissues. Our findings identify elastase as the innate regulator that blunts the adjuvant activity of alum. They also demonstrate that vaccination via mucosal routes is not an absolute requirement for antibody responses in mucosal tissues and secretions. Supplementation of an alum-based vaccine containing SARS-CoV-2 spike protein subunit 1 as antigen increased anti–SARS-CoV-2 immunity in the blood and mucosal secretions in mice. Thus, this strategy could help in the development of future protein-based vaccines against SARS-CoV-2. Alum, used as an adjuvant in injected vaccines, promotes T helper 2 (Th2) and serum antibody (Ab) responses. However, it fails to induce secretory immunoglobulin (Ig) A (SIgA) in mucosal tissues and is poor in inducing Th1 and cell-mediated immunity. Alum stimulates interleukin 1 (IL-1) and the recruitment of myeloid cells, including neutrophils. We investigated whether neutrophil elastase regulates the adjuvanticity of alum, and whether a strategy targeting neutrophil elastase could improve responses to injected vaccines. Mice coadministered a pharmacological inhibitor of elastase, or lacking elastase, developed high-affinity serum IgG and IgA antibodies after immunization with alum-adsorbed protein vaccines, including the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). These mice also developed broader antigen-specific CD4 + T cell responses, including high Th1 and T follicular helper (Tfh) responses. Interestingly, in the absence of elastase activity, mucosal SIgA responses were induced after systemic immunization with alum as adjuvant. Importantly, lack or suppression of elastase activity enhanced the magnitude of anti–SARS-CoV-2 spike subunit 1 (S1) antibodies, and these antibodies reacted with the same epitopes of spike 1 protein as sera from COVID-19 patients. Therefore, suppression of neutrophil elastase could represent an attractive strategy for improving the efficacy of alum-based injected vaccines for the induction of broad immunity, including mucosal immunity.
【저자키워드】 SARS-CoV-2, mucosal immunity, Elastase, alum, neutrophil elastase inhibitor, 【초록키워드】 Neutrophils, antibodies, Efficacy, Vaccine, coronavirus, vaccination, Immunity, Vaccines, antibody, Antibody Response, neutrophil, Th1, Th2, myeloid cells, severe acute respiratory syndrome Coronavirus, CD4, immunization, Spike protein, Antigen, Protein, Epitopes, T cell, Antibody responses, protective antibodies, interleukin, Immunoglobulin, mice, sera, response, SARS-CoV-2 spike protein, T cell responses, adjuvant, serum antibody, recruitment, inhibitor, epitope, IL-1, Neutrophil elastase, COVID-19 patients, Blood, Cell-mediated immunity, Tfh, Protective antibody, mucosal, Protein subunit, regulate, Elastase, alum, Support, innate response, T helper, acute respiratory syndrome, Serine, subunit, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, suppression, IgA antibodies, bloodstream, help, serum IgG, serine protease, SIgA, mucosal tissues, pharmacological, alum adjuvant, responses, IMPROVE, adjuvanticity, identify, lack, investigated, injected, absence, the spike protein, promote, magnitude, induce, mucosal route, stimulate, IgA antibody, blunt, follicular, mucosal secretion, mucosal tissue, protein-based vaccine, Significance, 【제목키워드】 Immunity, inhibition, mucosal, ENhance, promote,